Stay updated with breaking news from For Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioMérieux receives Dual 510 clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Marcy-l'Étoile , March 27th, 2023 -...
BioMérieux - First-Half 2023 Results €1,770 million in first-half 2023 sales, up 8.3% like-for-like; organic growth excluding...
Reyna, J. The Court affirmed a decision by the PTAB in a post-grant review denying an appellant's motion to substitute claims of a patent directed to a botulinum toxin composition.
FDA clearance for multiplex PCR-based BIOFIRE SPOTFIRE Respiratory (R) Panel Mini.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated its...